Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by mmarquison Apr 30, 2002 11:58pm
192 Views
Post# 5066093

RE: Competing patent applications

RE: Competing patent applicationsBlueChip: I'm new to the board; trying to read-in as quickly as possible. Went long yesterday. Felt I needed to do so quickly as the phase I/II glio trials are starting and expected all the emerging news would drive up the price. Hope I made a good choice, but now am doing some quick catch-up before decideing if I'll stay around (might say backward DD). The patents noted in your previous post: are they on behalf of the group that was written up in last weekend's G&M, specifically the Mr. White case? If so do filers have a commercial affiliation? What is their business name? I get the sense from your comments they are seen as commercial competitors (and academic as well since there appears to be some potential disagreement on who owns the intellectual property rights. Is this likely to become a "battle royal"?). BTW, althougth I'm normally very frustrated by bashers- those who are mindlessly negative- as a new investor attempting to find the "truthful balance", I somewhat appreciate well considered and factual posts that bring fresh thinking. Believe me ????(can't remember her/his name, but the one everyone seton tonight) he/she IS BALANCED compared to the nuts and creeps on some other boards. In my SHouse experience this is board has the best posters I've seen. Regards to all. MM
Bullboard Posts